Authors

Mark Orchard
Recent : By Any Genes Necessary: The Role of MEAs for Gene Therapies

Senior Analyst, Cogentia

Stanton R. Mehr
Recent : Primary Care in Crisis: PCP Navigation in a Specialty World

Freelance writer who covers pharmaceutical care and clinical topics, health policy, and drug coverage issues

Maria Lopez, Digital Strategist, The Agency Network at MJH Life Sciences
Recent : To post or not to post
Jayne Hornung
Recent : When Will Payers Improve Coverage of Prescription Digital Therapeutics?

Chief clinical officer,

Deepak Patil
Recent : Being KOL-Centric: More Meaningful Expert Engagement
Markus Gershater
Recent : Labs and Computing Power: The Missing Link for a Revolution by 2030

Chief Scientific Officer and Co-founder, Synthace

Nadia Khatri, Brand Insights Contributor, Director of Omnichannel Strategy, BioPharm Communications
Recent : Engaging and Educating HCPs with KOL-Based Paid Social

Nadia Khatri is a Director of Omnichannel Strategy at BioPharm Communications, seeking opportunities for growth across all categories in the pharmaceutical space. She is focused on understanding the digitization of healthcare and the implications of major market disruptions.

Dae Y. Lee, Esq.
Recent : The Consolidated Appropriations Act and PBM Transparency

Dae Y. Lee is a pharmacist attorney in Frier Levitt’s life sciences department.

Jerry Temko
Recent : It’s Time to Get Creative Hiring in a Post-Brexit European Life Sciences Market

Managing director, in-house counsel practice, Major, Lindsey & Africa

Jen Nixon
Recent : ESG: Applying Lessons From Consumer Market